Clinical Trial: Page 2

HIV vaccine trial begins enrollment in U.S., South Africa
By LabPulse.com staff writers
A clinical trial for a preventive HIV vaccine has begun enrollment in both the U.S. and South Africa.
September 25, 2023
Vial Vaccine Vial Tech Social
NIH starts early-phase trial of second-generation universal flu vaccine candidate
By Nick Paul Taylor
The U.S. National Institutes of Health (NIH) has begun an early-phase clinical trial of its second-generation universal flu vaccine candidate.
September 20, 2023
Needle Shot Vaccine Teenager Social
Moderna’s mRNA flu shot yields promising results in phase III trial
By LabPulse.com staff writers
Moderna announced that its mRNA flu shot that is in development has met its primary endpoints in a phase III trial, generating a stronger immune response than a commercially available flu vaccine.
September 15, 2023
Vaccine Injection Woman Social
Roche’s Alecensa improves survival in postsurgery lung cancer patients in late-phase trial
By Nick Paul Taylor
Roche’s Alecensa has improved disease-free survival in non-small cell lung cancer patients, positioning the Swiss drugmaker to apply to expand the product label.
September 8, 2023
Cancer Lung Social
Twist Bioscience, Ono Pharmaceutical to collaborate on autoimmune disease drug development
By LabPulse.com staff writers
Synthetic biology and genomics company Twist Bioscience has entered into a collaboration with Ono Pharmaceutical, one of the largest pharmaceutical companies in Japan, to discover and develop drugs for autoimmune diseases.
September 5, 2023
Test Tube Liquid Sample Social
Oral therapy combination yields promising results in multiple myeloma study
By LabPulse.com staff writers
A new agent that can be taken once daily in pill form showed promising results in a clinical trial when used in combination with a steroid in patients with multiple myeloma who had relapsed and stopped responding to currently available therapies.
September 1, 2023
Multiple Myeloma Social
Grail partners with LGBTQ+ group on study of cancer detection blood test
By Nick Paul Taylor
Grail has partnered with the Whitman-Walker Institute and the Cancer Support Community to assess the feasibility of using its multicancer early detection (MCED) Galleri blood test in a real-world setting.
September 1, 2023
Cancer Cell Microenvironment Social
Roche data release raises hopes TIGIT drugs can improve lung cancer survival
By Nick Paul Taylor
Roche's inadvertent release of interim data from its ongoing late-phase clinical trial has raised hopes that its anti-TIGIT immunotherapy may improve the survival rate of lung cancer patients.
August 25, 2023
Lung Cancer Hotspot Social
Astellas snags chance to license Poseida cell therapy in $50M deal
By Nick Paul Taylor
The agreement gives Astellas first refusal for partnering on P-MUC1C-ALLO1, an allogeneic chimeric antigen receptor (CAR) T cell therapy product candidate that Poseida is developing as a treatment for solid tumors.
August 9, 2023
T Cell Social
Pfizer invests $25M to support development of CellCentric’s blood cancer candidate
By Nick Paul Taylor
Evidence of the roles p300 and CBP play in multiple cancers led CellCentric to generate chemical hits against the proteins, ultimately leading to the development of inobrodib.
July 13, 2023
Blood Cells Vessel Social
Reveal Genomics highlights results for breast cancer predictive test in phase II clinical trial
By LabPulse.com staff writers
Precision oncology firm Reveal Genomics announced that its HER2Dx genomic test for HER2+ breast cancer has been validated in the PHERGain phase II clinical trial.
June 15, 2023
Breast Mammo Social
Burning Rock Biotech highlights breast cancer study using its genomic profiling test
By LabPulse.com staff writers
In the study, OncoScreen Plus was used to determine activating mutations in PIK3CA and AKT1 and inactivating alterations in PTEN genes for patients in the trial who were enrolled in China.
June 8, 2023
Genome Sequence Barcode Social
Previous Page
Page 2 of 18
Next Page